Literature DB >> 15533941

Huntingtin interacting protein 1 (HIP1) regulates clathrin assembly through direct binding to the regulatory region of the clathrin light chain.

Valerie Legendre-Guillemin1, Martina Metzler, Jean-Francois Lemaire, Jacynthe Philie, Lu Gan, Michael R Hayden, Peter S McPherson.   

Abstract

Huntingtin interacting protein 1 (HIP1) is a component of clathrin coats. We previously demonstrated that HIP1 promotes clathrin assembly through its central helical domain, which binds directly to clathrin light chains (CLCs). To better understand the relationship between CLC binding and clathrin assembly we sought to dissect this interaction. Using C-terminal deletion constructs of the HIP1 helical domain, we identified a region between residues 450 and 456 that is required for CLC binding. Within this region, point mutations showed the importance of residues Leu-451, Leu-452, and Arg-453. Mutants that fail to bind CLC are unable to promote clathrin assembly in vitro but still mediate HIP1 homodimerization and heterodimerization with the family member HIP12/HIP1R. Moreover, HIP1 binding to CLC is necessary for HIP1 targeting to clathrin-coated pits and clathrin-coated vesicles. Interestingly, HIP1 binds to a highly conserved region of CLC previously demonstrated to regulate clathrin assembly. These results suggest a role for HIP1/CLC interactions in the regulation of clathrin assembly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533941     DOI: 10.1074/jbc.M408430200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Actin is required for endocytosis at the apical surface of Madin-Darby canine kidney cells where ARF6 and clathrin regulate the actin cytoskeleton.

Authors:  Tehila Hyman; Miri Shmuel; Yoram Altschuler
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

2.  Clathrin is important for normal actin dynamics and progression of Sla2p-containing patches during endocytosis in yeast.

Authors:  Thomas M Newpher; Sandra K Lemmon
Journal:  Traffic       Date:  2006-05       Impact factor: 6.215

3.  Novel function of clathrin light chain in promoting endocytic vesicle formation.

Authors:  Thomas M Newpher; Fatima-Zahra Idrissi; Maria Isabel Geli; Sandra K Lemmon
Journal:  Mol Biol Cell       Date:  2006-07-26       Impact factor: 4.138

4.  Crystal structure at 2.8 A of the DLLRKN-containing coiled-coil domain of huntingtin-interacting protein 1 (HIP1) reveals a surface suitable for clathrin light chain binding.

Authors:  Joel A Ybe; Sanjay Mishra; Stephen Helms; Jay Nix
Journal:  J Mol Biol       Date:  2006-12-23       Impact factor: 5.469

5.  Clathrin-dependent association of CVAK104 with endosomes and the trans-Golgi network.

Authors:  Michael Düwel; Ernst J Ungewickell
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

Review 6.  Regulating cytoskeleton-based vesicle motility.

Authors:  Heidi Hehnly; Mark Stamnes
Journal:  FEBS Lett       Date:  2007-02-20       Impact factor: 4.124

7.  A Hip1R-cortactin complex negatively regulates actin assembly associated with endocytosis.

Authors:  Christophe Le Clainche; Barbara S Pauly; Claire X Zhang; Asa E Y Engqvist-Goldstein; Kimberley Cunningham; David G Drubin
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

8.  Qualitative and quantitative alterations in the parietal cell domain in chronic gastritis.

Authors:  Carlos A Rubio; Gabriella Nesi
Journal:  Virchows Arch       Date:  2011-04-15       Impact factor: 4.064

9.  Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI).

Authors:  Qian Niu; Joel A Ybe
Journal:  J Mol Biol       Date:  2007-11-22       Impact factor: 5.469

Review 10.  Functions of actin in endocytosis.

Authors:  Alastair S Robertson; Elizabeth Smythe; Kathryn R Ayscough
Journal:  Cell Mol Life Sci       Date:  2009-03-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.